Biocon Market Cap

Biocon has a market cap or net worth of 630.68 billion as of March 9, 2026. Its market cap has increased by 50.84% in one year.

Market Cap

630.68B

Enterprise Value

797.52B

Revenue

168.27B

Ranking

n/a

PE Ratio

81.86

Stock Price

389.70

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 630.68B, an increase of 1,288.76%. That is a compound annual growth rate of 12.74%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	630.68B	19.98%
Dec 31, 2025	525.64B	20.22%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anthem Biosciences	372.46B
OneSource Specialty Pharma	169.70B
Concord Biotech	126.29B
Blue Jet Healthcare	66.84B
Supriya Lifescience	50.54B
Zota Health Care	40.47B
Dishman Carbogen Amcis	25.75B
Panacea Biotec	19.63B

Market Cap Rankings